Integrative Cancer Epidemiology Programme 2
Publications
-
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review
Journal article
TAYLOR J. et al, (2022), Genetics in Medicine
The health economics component of this major programme of research on cancer epidemiology will develop new causal evidence on the effect of cancers on healthcare cost and on health-related quality of life. The work will also explore the potential for genetic data to influence the cost-effectiveness of screening programmes.
Oxford project lead:
-
Padraig Dixon
Senior Researcher in Health Economics
Collaborators:
Richard Martin, University of Bristol
Dates:
2020 – 2025
Funder:
Cancer Research UK
Our team
-
Stavros Petrou
Academic Research Lead in Health Economics
-
Lucy Abel
Health Economist, DPhil student
-
Felix Achana
Senior Researcher in Health Economics
-
Laura Armitage
Wellcome Trust Doctoral Research Fellow
-
Corneliu Bolbocean
Senior Researcher in Health Economics
-
Laia Bosque Mercader
Research Fellow in Health Economics
-
Lin Bowker-Lonnecker
DPhil Student
-
John Buckell
Researcher
-
Padraig Dixon
Senior Researcher in Health Economics
-
Patrick Fahr
Quantitative Researcher
-
Carmen Fierro Martinez
NIHR Pre-Doctoral Fellow
-
Nadeem Hussein
NIHR Pre-Doctoral Fellow
-
Joseph Kwon
Researcher in Health Economics
-
Sungwook Kim
Senior researcher in Health Economics
-
Joan Madia
Researcher in Health Economics
-
Joaquim Vidiella Martin
Researcher in Economics
-
Catia Nicodemo
Senior Research Fellow in Health Economics
-
Olu Onyimadu
Health Economist, DPhil Candidate
-
May Png
Senior Researcher in Health Economics
-
Stuart Redding
Project Lead, Centre for Health Service Economics & Organisation
-
Elizabeth-Ann Schroeder
Senior Researcher in Health Economics
-
Apostolos Tsiachristas
Associate Professor
-
Raphael Wittenberg
Deputy Director, Centre for Health Service Economics and Organisation
-
Yaling Yang
Senior Researcher in Health Economics